The potential interaction between COVID-19 vaccines and clozapine: A novel approach for clinical trials.

Bayraktar, Izgi; Yalçin, Nadir; Demirkan, Kutay

Bayraktar, Izgi; Yalçin, Nadir; Demirkan, Kutay.

Bayraktar I; Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Yalçin N; Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Demirkan K; Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.

Int J Clin Pract ; 75(8): e14441, 2021 Aug.

Article in English | MEDLINE | ID: covidwho-1319305

Subject(s)

Antipsychotic Agents; COVID-19; Clozapine; Antipsychotic Agents/adverse effects; COVID-19 Vaccines; Clozapine/adverse effects; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antipsychotic Agents / Clozapine / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Int J Clin Pract Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Ijcp.14441

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google